Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single Center, Open Label, Expanded Access Study of QRX003 Lotion in Subjects With Netherton Syndrome

NCT06953466 is registered in ClinicalTrials.gov with Quoin Pharmaceuticals as lead sponsor.

NCT NCT06953466
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06953466 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single Center, Open Label, Expanded Access Study of QRX003 Lotion in Subjects With Netherton Syndrome
Lead sponsor
Quoin Pharmaceuticals
Phase
Phase 2/3
Overall status
Recruiting
Start date
October 6, 2025
Completion date
December 30, 2026
Enrollment
8 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

netherton syndrome